OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Characterization of the SARS‐CoV ‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors
Yipeng Cao, Rui Yang, Imshik Lee, et al.
Protein Science (2021) Vol. 30, Iss. 6, pp. 1114-1130
Open Access | Times Cited: 100
Yipeng Cao, Rui Yang, Imshik Lee, et al.
Protein Science (2021) Vol. 30, Iss. 6, pp. 1114-1130
Open Access | Times Cited: 100
Showing 1-25 of 100 citing articles:
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development
Shilin Zhou, Panpan Lv, Mingxue Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114242-114242
Open Access | Times Cited: 42
Shilin Zhou, Panpan Lv, Mingxue Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114242-114242
Open Access | Times Cited: 42
The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation
Zhaolong Li, Pengfei Hao, Zhilei Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Zhaolong Li, Pengfei Hao, Zhilei Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation
Jérôme Cattin‐Ortolá, Lawrence G. Welch, Sarah Maslen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 99
Jérôme Cattin‐Ortolá, Lawrence G. Welch, Sarah Maslen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 99
Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
Spike protein of SARS-CoV-2 variants: a brief review and practical implications
Kattlyn Laryssa Candido, Caio Ricardo Eich, Luciana Oliveira de Fariña, et al.
Brazilian Journal of Microbiology (2022) Vol. 53, Iss. 3, pp. 1133-1157
Open Access | Times Cited: 33
Kattlyn Laryssa Candido, Caio Ricardo Eich, Luciana Oliveira de Fariña, et al.
Brazilian Journal of Microbiology (2022) Vol. 53, Iss. 3, pp. 1133-1157
Open Access | Times Cited: 33
The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target
Teresa Santos-Mendoza
Viruses (2023) Vol. 15, Iss. 4, pp. 1000-1000
Open Access | Times Cited: 18
Teresa Santos-Mendoza
Viruses (2023) Vol. 15, Iss. 4, pp. 1000-1000
Open Access | Times Cited: 18
Perturbation of the host cell Ca2+ homeostasis and ER-mitochondria contact sites by the SARS-CoV-2 structural proteins E and M
Elena Poggio, Francesca Vallese, Andreas Hartel, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 18
Elena Poggio, Francesca Vallese, Andreas Hartel, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 18
SARS-CoV-2 envelope protein triggers depression-like behaviors and dysosmia via TLR2-mediated neuroinflammation in mice
Wenliang Su, Jiahang Ju, Minghui Gu, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Wenliang Su, Jiahang Ju, Minghui Gu, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Research Advances on Swine Acute Diarrhea Syndrome Coronavirus
Chuancheng Liu, Wei‐Li Huang, Xinyan He, et al.
Animals (2024) Vol. 14, Iss. 3, pp. 448-448
Open Access | Times Cited: 5
Chuancheng Liu, Wei‐Li Huang, Xinyan He, et al.
Animals (2024) Vol. 14, Iss. 3, pp. 448-448
Open Access | Times Cited: 5
Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses
Fusheng Si, Ruisong Yu, Shijuan Dong, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 330-330
Open Access | Times Cited: 5
Fusheng Si, Ruisong Yu, Shijuan Dong, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 330-330
Open Access | Times Cited: 5
Conformational dynamics of the membrane protein of MERS-CoV in comparison with SARS-CoV-2 in ERGIC complex
Subha Yegnaswamy, Selvaa Kumar C, Ebtisam A. Aldaais
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-15
Closed Access
Subha Yegnaswamy, Selvaa Kumar C, Ebtisam A. Aldaais
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-15
Closed Access
Navigating COVID-19: advancements in therapeutics and viral filtration technologies for Today's challenges and tomorrow's solutions
Devesh U. Kapoor, Bhavna Kumar, Manmohan Singhal, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106741-106741
Closed Access
Devesh U. Kapoor, Bhavna Kumar, Manmohan Singhal, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106741-106741
Closed Access
Subcellular localization of SARS-CoV-2 E and 3a proteins along the secretory pathway
Joshua J. Hinkle, Kathleen A. Trychta, Emily S. Wires, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Open Access
Joshua J. Hinkle, Kathleen A. Trychta, Emily S. Wires, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Open Access
Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells
Koya Miura, Youichi Suzuki, Kotaro Ishida, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 12
Koya Miura, Youichi Suzuki, Kotaro Ishida, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 12
Glycosylation in SARS-CoV-2 variants: A path to infection and recovery
Arya Aloor, Rajaguru Aradhya, P. Dilip Venugopal, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115335-115335
Open Access | Times Cited: 21
Arya Aloor, Rajaguru Aradhya, P. Dilip Venugopal, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115335-115335
Open Access | Times Cited: 21
Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation
Z. W. Wang, Manman Qiu, Yue Ji, et al.
Journal of Virology (2024) Vol. 98, Iss. 10
Closed Access | Times Cited: 3
Z. W. Wang, Manman Qiu, Yue Ji, et al.
Journal of Virology (2024) Vol. 98, Iss. 10
Closed Access | Times Cited: 3
Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins
Yanlei Zhu, Flavio Alvarez, Nicolas Wolff, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 17
Yanlei Zhu, Flavio Alvarez, Nicolas Wolff, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 17
COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis
Attilio Cavezzi, Roberto Menicagli, Emidio Troiani, et al.
F1000Research (2022) Vol. 11, pp. 102-102
Open Access | Times Cited: 17
Attilio Cavezzi, Roberto Menicagli, Emidio Troiani, et al.
F1000Research (2022) Vol. 11, pp. 102-102
Open Access | Times Cited: 17
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100079-100079
Open Access | Times Cited: 17
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100079-100079
Open Access | Times Cited: 17
SARS-CoV-2 Harnesses Host Translational Shutoff and Autophagy To Optimize Virus Yields: the Role of the Envelope (E) Protein
Hope Waisner, Brandon Grieshaber, Rabina Saud, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Hope Waisner, Brandon Grieshaber, Rabina Saud, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 9
The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus
Shaza S. Issa, С. В. Сокорнова, Roman R. Zhidkin, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1862-1862
Open Access | Times Cited: 15
Shaza S. Issa, С. В. Сокорнова, Roman R. Zhidkin, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1862-1862
Open Access | Times Cited: 15
Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets
Tao Yang, Si Chun Wang, Linyan Ye, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 247-268
Closed Access | Times Cited: 8
Tao Yang, Si Chun Wang, Linyan Ye, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 247-268
Closed Access | Times Cited: 8
